News Related to Epstein-Barr Virus

Related coverage linked through entity extraction aliases.

Immunic presents new CALIPER trial data showing reduced MS brain lesions

Mar 14, 2026

Immunic Inc presented additional data from its Phase 2 CALIPER trial at the ACTRIMS Forum, showing Vidofludimus calcium reduced both acute and chronic brain lesions in progressive multiple sclerosis patients and demonstrated clinical evidence of reduced EBV reactivation.

Scientists Develop Universal Vaccine Platform Protecting Against Multiple Respiratory Pathogens

Mar 11, 2026

Researchers have created a nasal vaccine platform that protects mice against flu, COVID-19, SARS, and bacterial infections by activating both innate and adaptive immune systems, offering a fundamentally different approach to disease prevention.